Copyright Reports & Markets. All rights reserved.

Global Rheumatology Drugs Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Rheumatology Drugs Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Disease Modifying Anti-rheumatic Drugs
    • 1.4.3 Nonsteroidal Anti-inflammatory Drugs
    • 1.4.4 Corticosteroids
    • 1.4.5 Uric Acid Drugs
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Rheumatology Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Online Pharmacy
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Rheumatology Drugs Market Perspective (2015-2026)
  • 2.2 Global Rheumatology Drugs Growth Trends by Regions
    • 2.2.1 Rheumatology Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Rheumatology Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Rheumatology Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Rheumatology Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Rheumatology Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Rheumatology Drugs Players by Market Size
    • 3.1.1 Global Top Rheumatology Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Rheumatology Drugs Market Concentration Ratio
    • 3.2.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2019
  • 3.3 Rheumatology Drugs Key Players Head office and Area Served
  • 3.4 Key Players Rheumatology Drugs Product Solution and Service
  • 3.5 Date of Enter into Rheumatology Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Rheumatology Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Rheumatology Drugs Market Size by Application (2015-2020)
  • 5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Rheumatology Drugs Market Size (2015-2020)
  • 6.2 Rheumatology Drugs Key Players in North America (2019-2020)
  • 6.3 North America Rheumatology Drugs Market Size by Type (2015-2020)
  • 6.4 North America Rheumatology Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Rheumatology Drugs Market Size (2015-2020)
  • 7.2 Rheumatology Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Rheumatology Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Rheumatology Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Rheumatology Drugs Market Size (2015-2020)
  • 8.2 Rheumatology Drugs Key Players in China (2019-2020)
  • 8.3 China Rheumatology Drugs Market Size by Type (2015-2020)
  • 8.4 China Rheumatology Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Rheumatology Drugs Market Size (2015-2020)
  • 9.2 Rheumatology Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Rheumatology Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Rheumatology Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Rheumatology Drugs Market Size (2015-2020)
  • 10.2 Rheumatology Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Rheumatology Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Rheumatology Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Rheumatology Drugs Market Size (2015-2020)
  • 11.2 Rheumatology Drugs Key Players in India (2019-2020)
  • 11.3 India Rheumatology Drugs Market Size by Type (2015-2020)
  • 11.4 India Rheumatology Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Rheumatology Drugs Market Size (2015-2020)
  • 12.2 Rheumatology Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Rheumatology Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Rheumatology Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Takeda Pharmaceutical
    • 13.1.1 Takeda Pharmaceutical Company Details
    • 13.1.2 Takeda Pharmaceutical Business Overview
    • 13.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
    • 13.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2015-2020))
    • 13.1.5 Takeda Pharmaceutical Recent Development
  • 13.2 Sanofi
    • 13.2.1 Sanofi Company Details
    • 13.2.2 Sanofi Business Overview
    • 13.2.3 Sanofi Rheumatology Drugs Introduction
    • 13.2.4 Sanofi Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.2.5 Sanofi Recent Development
  • 13.3 Genentech
    • 13.3.1 Genentech Company Details
    • 13.3.2 Genentech Business Overview
    • 13.3.3 Genentech Rheumatology Drugs Introduction
    • 13.3.4 Genentech Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.3.5 Genentech Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview
    • 13.4.3 Novartis Rheumatology Drugs Introduction
    • 13.4.4 Novartis Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Janssen Biotech
    • 13.5.1 Janssen Biotech Company Details
    • 13.5.2 Janssen Biotech Business Overview
    • 13.5.3 Janssen Biotech Rheumatology Drugs Introduction
    • 13.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.5.5 Janssen Biotech Recent Development
  • 13.6 Amgen
    • 13.6.1 Amgen Company Details
    • 13.6.2 Amgen Business Overview
    • 13.6.3 Amgen Rheumatology Drugs Introduction
    • 13.6.4 Amgen Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.6.5 Amgen Recent Development
  • 13.7 AbbVie
    • 13.7.1 AbbVie Company Details
    • 13.7.2 AbbVie Business Overview
    • 13.7.3 AbbVie Rheumatology Drugs Introduction
    • 13.7.4 AbbVie Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.7.5 AbbVie Recent Development
  • 13.8 Pfizer
    • 13.8.1 Pfizer Company Details
    • 13.8.2 Pfizer Business Overview
    • 13.8.3 Pfizer Rheumatology Drugs Introduction
    • 13.8.4 Pfizer Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.8.5 Pfizer Recent Development
  • 13.9 Bristol-Myers Squibb Company
    • 13.9.1 Bristol-Myers Squibb Company Company Details
    • 13.9.2 Bristol-Myers Squibb Company Business Overview
    • 13.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
    • 13.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.9.5 Bristol-Myers Squibb Company Recent Development
  • 13.10 Merck & Co.
    • 13.10.1 Merck & Co. Company Details
    • 13.10.2 Merck & Co. Business Overview
    • 13.10.3 Merck & Co. Rheumatology Drugs Introduction
    • 13.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2015-2020)
    • 13.10.5 Merck & Co. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Rheumatology Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Takeda Pharmaceutical
    Sanofi
    Genentech
    Novartis
    Janssen Biotech
    Amgen
    AbbVie
    Pfizer
    Bristol-Myers Squibb Company
    Merck & Co.

    Market segment by Type, the product can be split into
    Disease Modifying Anti-rheumatic Drugs
    Nonsteroidal Anti-inflammatory Drugs
    Corticosteroids
    Uric Acid Drugs
    Others
    Market segment by Application, split into
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now